218 related articles for article (PubMed ID: 22286580)
1. Personalized cancer medicine.
Marmé D; Hallek M
Onkologie; 2012; 35 Suppl 1():2. PubMed ID: 22286580
[No Abstract] [Full Text] [Related]
2. Systems medicine: a real approach for future personalized oncology?
Roukos DH
Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782
[No Abstract] [Full Text] [Related]
3. ["Hidden hierarchical thinking is not up to date anymore": an interview with Johannes Bruns by Stephanie Hügler].
Bruns J
Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S20-2. PubMed ID: 21452102
[No Abstract] [Full Text] [Related]
4. The role of molecular diagnostics in cancer diagnosis and treatment.
Ozretić L; Heukamp LC; Odenthal M; Buettner R
Onkologie; 2012; 35 Suppl 1():8-12. PubMed ID: 22286582
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trials and personalized medicine in oncology?].
Arnold D; Bokemeyer C
Onkologie; 2010; 33 Suppl 7():25-9. PubMed ID: 20926911
[TBL] [Abstract][Full Text] [Related]
6. [Personalized medicine in oncology: from hope to reality].
Besse B; Soria JC
Rev Prat; 2012 Feb; 62(2):245-6. PubMed ID: 22408877
[No Abstract] [Full Text] [Related]
7. Recent developments and future perspectives of personalized oncology.
Grüllich C; von Kalle C
Onkologie; 2012; 35 Suppl 1():4-7. PubMed ID: 22286581
[TBL] [Abstract][Full Text] [Related]
8. Translational medicine promising personalized therapy in oncology.
Zeng YX; Zhang XS; Liu Q
Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
[No Abstract] [Full Text] [Related]
9. Personalised medicine in oncology: questions for the next 20 years.
Blay JY; Lacombe D; Meunier F; Stupp R
Lancet Oncol; 2012 May; 13(5):448-9. PubMed ID: 22554539
[No Abstract] [Full Text] [Related]
10. [Clinical research and human and social sciences at Institut National du Cancer (INCa)].
Amsellem N
Med Sci (Paris); 2012 Mar; 28 Spec No 1():6. PubMed ID: 22494649
[No Abstract] [Full Text] [Related]
11. It is fascinating to see how nowadays more and more knowledge of the molecular biological characteristics of the tumour lead to individualisation with surgery, radiotherapy and systemic treatment for patients with a malignancy. Introduction.
Bartelink H
Eur J Cancer; 2011 Sep; 47 Suppl 3():xxxv. PubMed ID: 21944037
[No Abstract] [Full Text] [Related]
12. Biomarkers and oncology: the path forward to a learning health system.
Yu PP; Hoffman MA; Hayes DF
Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
[No Abstract] [Full Text] [Related]
13. Introduction for: frontiers of personalized cancer medicine.
Kucherlapati R
Cancer J; 2011; 17(6):403-4. PubMed ID: 22157283
[No Abstract] [Full Text] [Related]
14. Circulating tumor cells: personalized medicine in interventional oncology?
Sheth RA; Hesketh R; Deipolyi AR; Oklu R
J Vasc Interv Radiol; 2013 Feb; 24(2):221-8. PubMed ID: 23265726
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
Freeman RA
J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
[No Abstract] [Full Text] [Related]
16. Point-of-care routine rapid screening: the future of cancer diagnosis?
Bossmann SH; Troyer DL
Expert Rev Mol Diagn; 2013 Mar; 13(2):107-9. PubMed ID: 23477549
[No Abstract] [Full Text] [Related]
17. Personalized treatment of colorectal cancer.
Arnold D; Stein A
Onkologie; 2012; 35 Suppl 1():42-8. PubMed ID: 22286587
[TBL] [Abstract][Full Text] [Related]
18. Personalized therapy in breast cancer.
Marmé F; Schneeweiss A
Onkologie; 2012; 35 Suppl 1():28-33. PubMed ID: 22286585
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy of soft tissue sarcomas.
Wardelmann E; Chemnitz JM; Wendtner CM
Onkologie; 2012; 35 Suppl 1():21-7. PubMed ID: 22286584
[TBL] [Abstract][Full Text] [Related]
20. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
